BTX stock forecast for 2023 – 2027
Last updated: September 30, 2023
Are you interested in Brooklyn ImmunoTherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BTX stock price in 2022-2027. Is BTX a good long term stock? When should I take profit in Brooklyn ImmunoTherapeutics stock? Buy or sell stock? Will BTX stock price go up? What are analysts’ forecasts for BTX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BTX stock returns are also predicted based on historical data.
According to our research, BTX stock is a awesome long-term investment. BTX share price has been in a bull cycle for the past year. Brooklyn ImmunoTherapeutics, Inc. stock trend is positive.
Brooklyn ImmunoTherapeutics company info
| Industry | Biotechnology |
| Address | Building A, Brooklyn, NY, 11220, United States |
| Website | https://www.brooklynitx.com |
Forecasting
52 Week High: 6.14484 USD
52 Week Low: 2.6826 USD
1 Year Forecast: 4.7187 USD
5 Year Forecast: 13.3552 USD
Agilent Technologies info
Market Cap: 141.56M
52 Week Change: -0.62%
52 Week High: 80.67 USD
52 Week Low: 2.38 USD
Beta: 0
50 Day Moving Average: 3.94
90 Day Moving Average: 5.350
200 Day Moving Average: 8.24
Resistance Level: 2.95494
Pivot Point: 2.73666
Support Level: 2.45686
Enterprise Value: 154,755,840
Forward P/E: -5.06
Forward EPS: -0.5
Profit Margin: 0.00%
Shares Outstanding: 52,043,800
EBITDA: -19.99
Held Percent Institutions: 10.94%
PEG Ratio (5Y): -0.28
Trailing EPS: -0.447
Brooklyn ImmunoTherapeutics stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
| March 2023 | 4.08 | 5.1 | 25% |
| March 2023 | 5.05 | 5.1 | 0.99% |
| May 2023 | 8 | 6.12 | -23.5% |
| June 2023 | 5 | 6 | 20% |
| August 2023 | 6.12 | 6.12 | 0% |
| November 2023 | 6.93 | 5.94 | -14.29% |
Brooklyn ImmunoTherapeutics Stock Forecast for 2024 | |||
| January 2024 | 6.86 | 5.88 | -14.29% |
| March 2024 | 6.06 | 7 | 15.51% |
| April 2024 | 7.07 | 10 | 41.44% |
| May 2024 | 9.9 | 8.08 | -18.38% |
| July 2024 | 7.84 | 7.92 | 1.02% |
| August 2024 | 7.92 | 7.84 | -1.01% |
| September 2024 | 8.16 | 8.08 | -0.98% |
| October 2024 | 8.08 | 9 | 11.39% |
| November 2024 | 9.18 | 7.92 | -13.73% |
| December 2024 | 7.84 | 8.82 | 12.5% |
Brooklyn ImmunoTherapeutics Stock Forecast for 2025 | |||
| January 2025 | 9 | 9.18 | 2% |
| March 2025 | 9 | 9 | 0% |
| March 2025 | 9 | 8.82 | -2% |
| April 2025 | 8.82 | 12.24 | 38.78% |
| May 2025 | 11.76 | 10.2 | -13.27% |
| June 2025 | 9.9 | 10 | 1.01% |
| July 2025 | 10.2 | 9.9 | -2.94% |
| August 2025 | 9.9 | 10.2 | 3.03% |
| September 2025 | 10 | 10.78 | 7.8% |
| October 2025 | 10.78 | 10.78 | 0% |
| November 2025 | 11 | 10.89 | -1% |
| December 2025 | 10.78 | 10.78 | 0% |
Brooklyn ImmunoTherapeutics Stock Forecast for 2026 | |||
| January 2026 | 10.89 | 11 | 1.01% |
| March 2026 | 11.22 | 10.78 | -3.92% |
| March 2026 | 11 | 10.89 | -1% |
| April 2026 | 10.89 | 14.14 | 29.84% |
| May 2026 | 14 | 12.12 | -13.43% |
| June 2026 | 12.12 | 12.12 | 0% |
| July 2026 | 11.76 | 12 | 2.04% |
| August 2026 | 11.76 | 11.88 | 1.02% |
| September 2026 | 12 | 13.13 | 9.42% |
| October 2026 | 13 | 13 | 0% |
| November 2026 | 13.26 | 13 | -1.96% |
| December 2026 | 12.87 | 12.87 | 0% |
Brooklyn ImmunoTherapeutics Stock Forecast for 2027 | |||
| January 2027 | 12.87 | 13 | 1.01% |